- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
January 2016
Does Distance Modify the Effect of Self-Testing in Oral Anticoagulation?
Self-testing of anticoagulation improves outcomes, but is expensive. One might assume it is more helpful for patients living farther from care, but the authors disprove this assumption.
Impact of a Scalable Care Transitions Program for Readmission Avoidance
The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.
The Introduction of Generic Risperidone in Medicare Part D
This study examines the plan characteristics associated with generic risperidone use and spending and adherence outcomes associated with use among Medicare Advantage Part D beneficiaries.
Care Pathways in US Healthcare Settings: Current Successes and Limitations, and Future Challenges
Care pathways influence quality of care and outcomes. Despite positive trends in development and implementation, further efforts in process transparency and evaluation are required.
Oral Anticoagulant Discontinuation in Patients With Nonvalvular Atrial Fibrillation
The risk of discontinuation of oral anticoagulant therapy (both warfarin and direct oral anticoagulant therapies [DOACs]) among nonvalvular atrial fibrillation patients was high. Although the hazard ratio for discontinuation favors DOACs, it is unlikely that the small difference in discontinuation relative to warfarin is clinically meaningful.
Outcomes Trends for Acute Myocardial Infarction, Congestive Heart Failure, and Pneumonia, 2005-2009
The 3 core measures of acute myocardial infarction, congestive heart failure, and pneumonia are the leading causes of hospital admissions and expenditures. Our study sets the benchmark foundation for outcome evaluations of CMS’s value-based purchasing program and the Affordable Care Act.
Analyzing factors associated with continuing care participation in patients with diabetes and with interrupted participation by patients enrolled in a diabetes pay-for-performance program.
